89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $39,795 | +24.4% | 2,100,000 | 0.0% | 1.85% | +17.5% |
Q1 2023 | $31,983 | -99.8% | 2,100,000 | +50.0% | 1.57% | +67.1% |
Q4 2022 | $17,822,000 | +119.9% | 1,400,000 | 0.0% | 0.94% | +106.1% |
Q3 2022 | $8,106,000 | +79.8% | 1,400,000 | 0.0% | 0.46% | +59.4% |
Q2 2022 | $4,508,000 | – | 1,400,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |